Plk5, a Polo Box Domain-Only Protein with Specific Roles in Neuron Differentiation and Glioblastoma Suppression

被引:104
作者
de Carcer, Guillermo [1 ,2 ]
Escobar, Beatriz [1 ,2 ]
Higuero, Alonso M. [3 ]
Garcia, Laura [1 ,2 ]
Anson, Alejandra [1 ,2 ]
Perez, Gema [4 ]
Mollejo, Manuela [4 ]
Manning, Gerard [5 ]
Melendez, Barbara [4 ]
Abad-Rodriguez, Jose [3 ]
Malumbres, Marcos [1 ,2 ]
机构
[1] Ctr Nacl Invest Oncol, Cell Div, E-28029 Madrid, Spain
[2] Ctr Nacl Invest Oncol, Canc Grp, E-28029 Madrid, Spain
[3] Hosp Nacl Paraplejicos, Membrane Biol & Axonal Repair Lab, Toledo, Spain
[4] Hosp Virgen Salud, Unidad Invest Patol Mol, Toledo, Spain
[5] Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, La Jolla, CA USA
关键词
CELL-CYCLE KINASES; CENTRIOLE DUPLICATION; DNA-DAMAGE; PHEOCHROMOCYTOMA CELLS; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; MAMMALIAN-CELLS; INK4; INHIBITORS; NERVOUS-SYSTEM; CANCER-THERAPY;
D O I
10.1128/MCB.00607-10
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polo-like kinases (Plks) are characterized by the presence of a specific domain, known as the polo box (PBD), involved in protein-protein interactions. Plk1 to Plk4 are involved in centrosome biology as well as the regulation of mitosis, cytokinesis, and cell cycle checkpoints in response to genotoxic stress. We have analyzed here the new member of the vertebrate family, Plk5, a protein that lacks the kinase domain in humans. Plk5 does not seem to have a role in cell cycle progression; in fact, it is downregulated in proliferating cells and accumulates in quiescent cells. This protein is mostly expressed in the brain of both mice and humans, and it modulates the formation of neuritic processes upon stimulation of the brain-derived neurotrophic factor (BDNF)/nerve growth factor (NGF)-Ras pathway in neurons. The human PLK5 gene is significantly silenced in astrocytoma and glioblastoma multiforme by promoter hypermethylation, suggesting a tumor suppressor function for this gene. Indeed, overexpression of Plk5 has potent apoptotic effects in these tumor cells. Thus, Plk5 seems to have evolved as a kinase-deficient PBD-containing protein with nervous system-specific functions and tumor suppressor activity in brain cancer.
引用
收藏
页码:1225 / 1239
页数:15
相关论文
共 64 条
[41]   Genetic cooperation between p21Cip1 and INK4 inhibitors in cellular senescence and tumor suppression [J].
Quereda, V. ;
Martinalbo, J. ;
Dubus, P. ;
Carnero, A. ;
Malumbres, M. .
ONCOGENE, 2007, 26 (55) :7665-7674
[42]   Inhibition of polo-like kinase 1 by blocking Polo-box domain-dependent protein-protein interactions [J].
Reindl, Wolfgang ;
Yuan, Juping ;
Kraemer, Andrea ;
Strebhardt, Klaus ;
Berg, Thorsten .
CHEMISTRY & BIOLOGY, 2008, 15 (05) :459-466
[43]   Revisiting the role of the mother centriole in centriole biogenesis [J].
Rodrigues-Martins, A. ;
Riparbelli, M. ;
Callaini, G. ;
Glover, D. M. ;
Bettencourt-Dias, M. .
SCIENCE, 2007, 316 (5827) :1046-1050
[44]   Polo-like kinase 3 is Golgi localized and involved in regulating Golgi fragmentation during the cell cycle [J].
Ruan, Q ;
Wang, Q ;
Me, SQ ;
Fang, YQ ;
Darzynkiewicz, Z ;
Guan, KL ;
Jhanwar-Uniyal, M ;
Dai, W .
EXPERIMENTAL CELL RESEARCH, 2004, 294 (01) :51-59
[45]   Structure of the Pseudokinase VRK3 Reveals a Degraded Catalytic Site, a Highly Conserved Kinase Fold, and a Putative Regulatory Binding Site [J].
Scheeff, Eric D. ;
Eswaran, Jeyanthy ;
Bunkoczi, Gabor ;
Knapp, Stefan ;
Manning, Gerard .
STRUCTURE, 2009, 17 (01) :128-138
[46]   Activity-induced polo-like kinase 2 is required for homeostatic plasticity of hippocampal neurons during epileptiform activity [J].
Seeburg, Daniel P. ;
Sheng, Morgan .
JOURNAL OF NEUROSCIENCE, 2008, 28 (26) :6583-6591
[47]   Critical role of CDK5 and Polo-like kinase 2 in homeostatic synaptic plasticity during elevated activity [J].
Seeburg, Daniel P. ;
Feliu-Mojer, Monica ;
Gaiottino, Johanna ;
Pak, Daniel T. S. ;
Sheng, Morgan .
NEURON, 2008, 58 (04) :571-583
[48]   Polo-like kinases in the nervous system [J].
Seeburg, DP ;
Morgan, DP ;
Sheng, M .
ONCOGENE, 2005, 24 (02) :292-298
[49]   Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors [J].
Sotillo, R ;
Dubus, P ;
Martín, J ;
de la Cueva, E ;
Ortega, S ;
Malumbres, M ;
Barbacid, M .
EMBO JOURNAL, 2001, 20 (23) :6637-6647
[50]   Opinion - Targeting polo-like kinase 1 for cancer therapy [J].
Strebhardt, K ;
Ullrich, A .
NATURE REVIEWS CANCER, 2006, 6 (04) :321-330